Clinical Trial Update: Efficacy and Safety Of Spil's Estradiol Vaginal Tablet [Phase 3]

View source ↗

Summary

Phase 3 trial update for Spil's estradiol vaginal tablet assessing efficacy and safety; study terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Vaginal Atrophy
• Vulvar Atrophy

Drugs mentioned

• Estradiol vaginal tablet (Spil's Estradiol Vaginal Tablet) (estradiol)

Snippet

Sponsor: Sun Pharmaceutical Industries Limited | Conditions: Vulvar Atrophy, Vaginal Atrophy | Phase 3 | Status: TERMINATED